Company Search:
Advanced Search
Sponsored Links
Juno Therapeutics Inc Company Snapshot
Juno Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Juno Therapeutics Inc with three other companies in this sector in the United States: Recro Pharma Inc (2016 sales of $69.34 million of which 100% was CDMO), Pfenex Inc ($60.19 million of which 100% was Biotechnology), and Veracyte Inc ($65.09 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Juno Therapeutics Inc
  Stock Performance Chart for Juno Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 67.81
(Figures in U.S. Dollars)
1 Week 39.1%   13 Weeks 47.4%  
4 Weeks 55.1%   52 Weeks 245.4%  
Juno Therapeutics Inc Key Data:
  Ticker: JUNO Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 79,356,000
(Year Ending Jan 2017).
Employees: 533
  Currency: U.S. Dollars Market Cap: 7,742,064,146
  Fiscal Yr Ends: December Shares Outstanding: 114,172,897
  Share Type: Common Closely Held Shares: 26,735,275
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.